Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.
A hospital patient suffers excruciating pain from what turns out to be a routine complication from elective surgery.
As her condition deteriorates, she and her family plead to see the doctor. But no doctor examines her until the next morning, when she goes into shock, is rushed into intensive care and dies.
Then, after her death, the hospital deletes portions of the woman’s medical file in what the woman’s family says is an attempt to cover up its horrendous mistakes.
The University of Utah has settled a lawsuit brought by the families of seven Chinese scholars killed in a 2003 van rollover, cutting short a two-week trial in a Salt Lake City courtroom.
State officials agreed to pay the plaintiffs, who include three men injured in the crash, nearly $500,000, just under a ceiling above which any settlement would require legislative approval. The U.’s offer came Thursday after the victims’ widows testified, leaving the jury in tears.
When the U. agreed to host the Chinese delegation in 2002, the school assumed responsibility for arranging the scholars’ travel within the U.S., court records indicate. Attorneys for the families alleged the university acted negligently by contracting with an unlicensed travel business in New York, which in turn hired a driver unqualified to pilot the oversized van that plunged off a snow-covered Pennsylvania highway and folded against a tree.
Coupled with a settlement from the van owner’s insurer, Friday’s settlement means the 10 families split $800,000.
Yaz and Yasmin are different from other combination birth control pills because they both contain a new type of progestin hormone known as drsp or drospirenone.
However, drospirenone has diuretic activity that can cause an increase in the user’s potassium levels, which can lead to dangerous health problems and is especially dangerous to users who have pre-existing kidney, liver and adrenal disease.
Yaz birth control increases the risk of pulmonary embolism, a condition in which an artery in the lung (part of the body’s pulmonary system) is blocked by a blood clot so the blood cannot get through to the lung.
All combined-hormone contraceptives (including Yaz birth control pills) increase a woman’s likelihood of suffering a pulmonary embolism, especially if she uses the contraceptive and:
* smokes
* is over 35
* has a family or personal history of pulmonary embolism
A federal appeals court has invalidated Bayer’s patent for the birth control pill Yasmin, allowing Teva Pharmaceuticals to produce the generic version, Ocella, without licensing the drug.
The U.S. Court of Appeals affirmed a lower court’s finding that the use of the progestin drospirenone that led to Yasmin were too obvious a pharmaceutical development for Bayer to patent.
Yasmin is an oral contraceptive that combines drospirenone with the estrogen component ethinyl estriadol to prohibit ovulation. While many birth control pills use ethinyl estriadol in combination with progestins, Yasmin was the first to use drospirenone.
Federal lawsuits have been filed in Ohio and Wisconsin alleging that since Yasmin/Yaz has been available on the market, it has been responsible for over 50 deaths and hundreds of health concerns due to complications with the medicine.
According to medical reports, patients with preexisting conditions such as diabetes, chronic high blood pressure, and several others are at a high risk of dangerous Yasmin side effects.
Yasmin and Yaz are monophasic, combined oral contraceptive pills, developed by Bayer AG. They are a combination of two main chemicals: drospirenone and ethinylestradiol. The complications seem to be a result of the drospirenone; as it is processed in the body, women can experience incresed levels of potassium in their blood over a period of time.
Complications arising from increased potassium levels in the blood include deep vein thrombosis, pulmonary embolism, stroke, blood clots and renal (kidney) complications.
YAZ (3 mg drospirenone/20 mcg ethinyl estradiol) is an oral contraceptive (OC) which is the first pill to combine 20 mcg of ethinyl estradiol (EE) with the so-called “fourth generation” progestin drospirenone (DRSP). YAZ was approved by the FDA in March 2006.
A company press release: “FDA Approves YAZ(R), The First Oral Contraceptive To Offer Drospirenone In A 24-Day, Active-Pill Regimen”, issued at the time of FDA approval.
File a report of side effects of YAZ/YASMIN to the FDA here.
Estrogen Combined With New Progestin Drospirenone (DRSP) Increase Risks Of Serious Side Effects Like Pulmonary Embolism, Stroke, And Heart Attack
All hormonal birth control options are associated with health risks. The oral contraceptive pills YAZ, Yasmin, and Ocella are associated with a possible higher rate of blood clots. Blood clots can cause serious side effects from YAZ, Yasmin, and Ocella – namely, stroke, heart attack, pulmonary embolism, and deep vein thrombosis.
A blood clot which begins in one part of the body can become a thromboembolism – essentially a blood clot that moves. A clot which moves into the lungs, heart, or brain is a very serious condition which can be fatal, and result in death.
Deep vein thrombosis, DVT, is a blood clot which most commonly forms in the leg. A pulmonary embolism, PE is a dangerous condition in which a clot forms in or has moved into the lungs. When a clot reaches the heart it can cause a heart attack, and clots in the brain can lead to strokes.
There are three possible reasons, or ways, that YAZ, Yasmin, and Ocella are suspected to increase a woman’s risk for thrombosis and thromboembolism: estrogen / progestin combination; DRSP’s link to hyperkalemia; and, DRSP’s diuretic effect.
There is a mounting number of lawsuits being filed against Bayer HealthCare Pharmaceuticals, and the plaintiff’s attorneys across the United States are calling this the latest mass tort. The product liability and personal injury lawsuits against the major pharmaceutical company all allege serious injuries and in some cases death is caused by the fourth generation oral contraceptives, Yaz and Yasmin.
While the two birth control pills are not exactly the same, they are very similar. They both contain the novel progestin component, drospirenone, which is a diuretic that has the potential to significantly increase a risk of increased potassium levels which can lead to both gallbladder damage and blood clots.
A Texas law firm is targeting generic drug giant Mylan Inc., along with other pharmaceutical companies, in product liability lawsuits related to the manufacture of pain patches.
The lawsuits involve the powerful painkiller fentanyl, which is applied to the skin in a patch for the slow release of the medication. In the Mylan lawsuits, the plaintiffs attribute 28 deaths to the patches.
Mylan makes the patches at its plant in St. Albans, Vt., which is operated by Mylan subsidiary Mylan Technologies Inc.
“We think there was a manufacturer defect,” according to the plaintiffs’ attorney. “What we don’t know is the exact nature of the defect.”
Mylan has denied liability in court filings.
Dallas Fort Worth Injury Lawyer Blog